trofosfamide has been researched along with Benign Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deroussent, A; Giraud, B; Hebert, G; Paci, A; Vassal, G; Veal, GJ | 1 |
| Frank, R; Latz, D; Nassar, N | 1 |
| Mauch, C | 1 |
| Boos, J; Hempel, G; Wagner, A | 1 |
| Falkson, G; Falkson, HC | 1 |
| Brock, N; Pohl, J; Schneider, B | 1 |
3 review(s) available for trofosfamide and Benign Neoplasms
| Article | Year |
|---|---|
Oxazaphosphorines: new therapeutic strategies for an old class of drugs.
Topics: Animals; Antineoplastic Agents, Alkylating; Cyclophosphamide; Cytochrome P-450 Enzyme System; Drug Delivery Systems; Drug Design; Genetic Therapy; Humans; Ifosfamide; Neoplasms | 2010 |
Trofosfamide in the palliative treatment of cancer: a review of the literature.
Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Lymphoma; Neoplasms; Palliative Care; Sarcoma; Treatment Outcome | 2004 |
Trofosfamide: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the oral treatment of cancer.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Alkylating; Cyclophosphamide; Humans; Neoplasms; Neoplasms, Experimental | 1997 |
1 trial(s) available for trofosfamide and Benign Neoplasms
| Article | Year |
|---|---|
Trofosfamide in the treatment of patients with cancer. A pilot trial.
Topics: Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Female; Humans; Male; Neoplasms | 1978 |
2 other study(ies) available for trofosfamide and Benign Neoplasms
| Article | Year |
|---|---|
[Metronomic chemotherapy. Should we change our thinking in the treatment of advanced tumors?].
Topics: Administration, Oral; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Bevacizumab; Breast Neoplasms; Busulfan; Cyclooxygenase 2 Inhibitors; Cyclophosphamide; Drug Therapy, Combination; Female; Forecasting; Humans; Male; Melanoma; Neoplasm Metastasis; Neoplasms; Prospective Studies; Quality of Life; Skin Neoplasms; Time Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2005 |
Basic principles in preclinical cancer chemotherapy.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Ifosfamide; Mechlorethamine; Mice; Neoplasms; Nitrogen Mustard Compounds; Rats | 1990 |